Table 1 Demographic and clinical characteristics of participants at baseline.

From: Heterogeneity in the association between prediabetes categories and reduction on glomerular filtration rate in a 5-year follow-up

Characteristics

Prediabetes

Normoglucose

p value

(n = 1072)

(n = 772)

Age (years), mean (SD)

59.1 (9.3)

56.6 (10.3)

 < 0.001

Male, n (%)

536 (50.0)

358 (46.4)

0.068

Smoking status, n(%)

Active smoker

182 (17.0)

170 (22.0)

0.003

Ex-smoker

409 (38.2)

244 (31.6)

Never smoker

481 (44.9)

358 (46.4)

Regular physical activity, n(%)

575 (53.7)

428 (55.4)

0.249

High-risk alcohol consumption, n(%)

140 (13.1)

83 (10.8)

0.078

Adherence Mediterranean diet score, n(%)

564 (52.6)

370 (47.9)

0.026

Daily consumption of fruit or vegetables, n(%)

919 (85.7)

653 (84.6)

0.269

Metabolic syndrome, n(%)

559 (52.1)

96 (12.4)

 < 0.001

Waist circumference (cm), mean (SD)

100.1 (12.3)

93.0 (11.8)

 < 0.001

BMI (kg/m2), mean (SD)

29.9 (4.8)

27.4 (4.4)

 < 0.001

Fasting plasma glucose (mg/dL), mean (SD)

105.2 (10.9)

87.0 (7.2)

 < 0.001

HbA1c (%), mean (SD)

5.8 (0.3)

5.3 (0.3)

 < 0.001

Hemoglobin (g/dL), n(%)

 ≥ 13.0

975 (91.0)

665 (86.1)

0.005

12.9–11.0

91 (8.5)

102 (13.2)

 ≤ 10.9

6 (0.6)

5 (0.6)

Hypertension, n(%)

708 (66.0)

359 (46.5)

 < 0.001

SBP (mmHg), mean (SD)

134.6 (16.0)

128.3 (15.3)

 < 0.001

DBP (mmHg), mean (SD)

81.2 (9.4)

79.0 (9.5)

 < 0.001

Total colesterol (mg/dL), mean (SD)

209.9 (37.4)

211.0 (37.5)

0.532

HDL-cholesterol (mg/dL), mean (SD)

54.4 (14.3)

58.5 (15.6)

 < 0.001

Non HDL-cholesterol (mg/dL), mean (SD)

129.6 (33.9)

129.8 (32.2)

0.899

Triglycerides (mg/dL), mean (SD)

132.3 (71.7)

114.4 (75.6)

 < 0.001

Use of ACEIs or ARBs, n(%)

396 (36.9)

182 (23.6)

 < 0.001

Creatinine(mg/dL), mean (SD)

0.8 (0.2)

0.8 (0.2)

0.760

eGFR (mL/min per 1.73 m2), mean (SD)

89.1 (13.7)

90.4 (13.4)

0.060

  1. SBP Systolic blood pressure, DBP Diastolic blood pressure, ACEIs Angiotensin converting enzyme inhibitors, ARBs Angiotensin receptor blockers, eGFR Estimated glomerular filtration rate.